Kuznetsov, Sergey
https://orcid.org/0000-0002-5662-9700 Senior Scientist, Institute for Molecular Medicine Finland
Nyckelord
BRCA1, GPRC5A, HTS, Rad51c, breast cancerAffiliering
Institute for Molecular Medicine Finland
Enheten
High Throughput Biomedicine Unit
Källa: ORCID
Title
Senior Scientist 2018 -
University of Helsinki
Enheten
Institute for Molecular Medicine Finland (FIMM)
Källa: ORCID
Title
FIMM-EMBL Group Leader 2008 - 2016
National Cancer Institute, NIH
Enheten
Mouse Cancer Genetics Program
Källa: ORCID
Title
post-doc 2002 - 2008
Utbildning
Grader
MSc 1.9.1995 - 31.12.1997 / St. Petersburg State University
PhD 13.3.1998 - 13.3.2002 / University of Kiel
BSc 1.9.1990 - 30.6.1995 / St. Petersburg State University
Publikationer (28)
P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathway
2023
High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma.
2021
Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
2019
Beviljade finansiering (4)
Identifying New Therapeutic Targets for Hereditary Breast CancersFinlands Akademi2011 - 2016
IDENTIFYING NEW THERAPEUTIC TARGETS FOR HEREDITARY BREAST CANCERSFinlands Akademi2011 - 2016
Developing personalized therapeutic approaches for BRCA1-mutated breast cancersCancer Society of Finland2011 - 2012
Aktiviteter och priser (1)
Functional Analysis of Human BRCA2 Variants Using a Mouse Embryonic Stem Cell-Based Assayannan aktivitet2010